These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8446560)

  • 1. Polyglandular autoimmune syndrome type III associated with coeliac disease and sarcoidosis.
    Papadopoulos KI; Hallengren B
    Postgrad Med J; 1993 Jan; 69(807):72-5. PubMed ID: 8446560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The occurrence of polyglandular autoimmune syndrome type III associated with coeliac disease in patients with sarcoidosis.
    Papadopoulos KI; Hörnblad Y; Hallengren B
    J Intern Med; 1994 Dec; 236(6):661-3. PubMed ID: 7989901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organospecific lymph node enlargement in autoimmune polyglandular syndrome.
    Hummel M; Banholzer P; Rabl W; Ziegler AG
    Diabetes Care; 1998 Sep; 21(9):1573-4. PubMed ID: 9727916
    [No Abstract]   [Full Text] [Related]  

  • 4. A case of autoimmune urticaria accompanying autoimmune polyglandular syndrome type III associated with Hashimoto's disease, type 1 diabetes mellitus, and vitiligo.
    Kasznicki J; Drzewoski J
    Endokrynol Pol; 2014; 65(4):320-3. PubMed ID: 25185856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.
    Van den Driessche A; Eenkhoorn V; Van Gaal L; De Block C
    Neth J Med; 2009 Dec; 67(11):376-87. PubMed ID: 20009114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implications for screening in the hypothyroid presentation of autoimmune polyglandular syndrome.
    Jolobe OMP
    Eur J Intern Med; 2019 Jan; 59():e23-e24. PubMed ID: 30174120
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitiligo associated with other autoimmune diseases: polyglandular autoimmune syndrome types 3B+C and 4.
    Amerio P; Tracanna M; De Remigis P; Betterle C; Vianale L; Marra ME; Di Rollo D; Capizzi R; Feliciani C; Tulli A
    Clin Exp Dermatol; 2006 Sep; 31(5):746-9. PubMed ID: 16803462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune polyglandular syndrome type 3 variant in rheumatoid arthritis.
    Horino T; Ogasawara M; Ichii O; Terada Y
    Rom J Intern Med; 2020 Mar; 58(1):40-43. PubMed ID: 31756165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyglandular autoimmune syndrome type III with a prevalence of cutaneous features.
    Capo A; Amerio P
    Clin Exp Dermatol; 2017 Jan; 42(1):61-63. PubMed ID: 27859474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type III Polyglandular Autoimmune Syndromes in children with type 1 diabetes mellitus.
    Ben-Skowronek I; Michalczyk A; Piekarski R; Wysocka-Łukasik B; Banecka B
    Ann Agric Environ Med; 2013; 20(1):140-6. PubMed ID: 23540228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperparathyroidism in a patient with autoimmune polyglandular syndrome.
    Pelletier-Morel L; Fabien N; Mouhoub Y; Boitard C; Larger E
    Intern Med; 2008; 47(21):1911-5. PubMed ID: 18981636
    [TBL] [Abstract][Full Text] [Related]  

  • 12.  An autoimmune polyglandular syndrome complicated with celiac disease and autoimmune hepatitis.
    Dieli-Crimi R; Núñez C; Estrada L; López-Palacios N
    Ann Hepatol; 2016; 15(4):588-91. PubMed ID: 27236159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case series in patients with enteropathy and granulomatous diseases.
    Kruis T; Jöhrens K; Moos V; Puls I; Siegmund B; Daum S; Schumann M
    BMC Gastroenterol; 2015 May; 15():62. PubMed ID: 26001889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central nervous system involvement in autoimmune polyglandular syndrome.
    Boz C; Velioglu S; Altunayoğlu V; Ozmenoglu M; Erem C
    Clin Neurol Neurosurg; 2003 Apr; 105(2):102-4. PubMed ID: 12691801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autoimmune polyendocrine syndrome type 2 associated with autoimmune hypophysitis and coeliac disease].
    Hrubisková K; Jackuliak P; Vanuga P; Pura M; Payer J
    Vnitr Lek; 2010 Nov; 56(11):1169-76. PubMed ID: 21250496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of common variable immunodeficiency and autoimmune polyglandular syndrome type 2.
    Topaloglu AK; Yuksel B; Yilmaz M; Mungan NO; Guneser S; Ozer G
    J Pediatr Endocrinol Metab; 2001 May; 14(5):565-6. PubMed ID: 11393580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitiligo and polyglandular autoimmune syndrome with selective IgA deficiency.
    Torrelo A; España A; Balsa J; Ledo A
    Int J Dermatol; 1992 May; 31(5):343-4. PubMed ID: 1587664
    [No Abstract]   [Full Text] [Related]  

  • 18. Polyglandular autoimmune diseases in a dermatological clinical setting: vitiligo-associated autoimmune diseases.
    Amerio P; Di Rollo D; Carbone A; Auriemma M; Marra ME; De Remigis P; Feliciani C; Tracanna M; Tulli A
    Eur J Dermatol; 2010; 20(3):354-8. PubMed ID: 20395193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Polyglandular autoimmune syndrome type II: epidemiology and forms of manifestation].
    Förster G; Krummenauer F; Kühn I; Beyer J; Kahaly G
    Dtsch Med Wochenschr; 1999 Dec; 124(49):1476-81. PubMed ID: 10629665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonischemic cardiomyopathy associated with autoimmune polyglandular syndrome type II.
    Nielsen TD; Steenbergen C; Russell SD
    Endocr Pract; 2007; 13(1):59-62. PubMed ID: 17360303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.